Real Time Touch

new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)

Real Time Touch

Filing Names

Mor Research Applications Ltd
Mor Research Applications

Mor Research Applications patents

Recent patent applications related to Mor Research Applications. Mor Research Applications is listed as an Agent/Assignee. Note: Mor Research Applications may have other listings under different names/spellings. We're not affiliated with Mor Research Applications, we're just tracking patents.

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "M" | Mor Research Applications-related inventors

Compositions and methods for prognosis of ovarian cancer

Described herein are compositions and methods for the prediction of the prognosis of ovarian cancer subjects. The present invention farther provides methods for distinguishing between histological subtypes of ovarian cancer tumors, and also methods and compositions liar the treatment or prevention of ovarian cancer. Specifically the invention relates to microRNA... Mor Research Applications

Compositions and methods for treating post-operative complications of cardiopulmonary surgery

Compositions and methods for treating damage inflicted by use of a cardio-pulmonary bypass (CPB) machine, particularly excessive bleeding and multi organ failure, by administering a pharmaceutical composition comprising alpha-1 antitrypsin (AAT-1).... Mor Research Applications

Interactive segmentation

A method for three-dimensional interactive segmentation, including: receiving a three-dimensional medical image of an interior volume of a patient's body; automatically performing three dimensional segmentation on the three dimensional medical image to detect and define a region of interest, wherein the performing of the three dimensional segmentation comprises automatically determining... Mor Research Applications

Compositions and methods for treatment of retinal degenerative diseases

This disclosure relates to compositions for use in treatment of Alzheimer's Disease, and/or a ocular and retinal degenerative disease, such as age related macular degeneration. The described compositions include effective amounts of LLMe, the hydrobromide form thereof, or functional derivatives thereof. Methods of treatment of a retinal degenerative disease of... Mor Research Applications

Prognostic methods and systems of treatment for acute lymphoblastic leukemia

Described herein are methods for determining the prognosis of a patient diagnosed with Acute Lymphoblastic Leukemia (ALL), and particularly determining the risk of disease relapse following standard treatment. Also described are systems of treatment that are directed by a health care provider, and which include the described prognostic methods and... Mor Research Applications

Compositions for treatment of acute lymphoblastic leukemia and methods of use thereof

Provided herein are compositions for treatment of Acute Lymphoblastic Leukemia (ALL) and methods of their use, including inhibiting ALL relapse. Further provided herein are systems of treatment that are directed by a health care provider, and which combine prognostic methods for determining ALL relapse and the described treatments.... Mor Research Applications

Extracellular matrix metalloproteinase inducer (emmprin) peptides and binding antibodies

Isolated peptides from the protein EMMPRIN (CD147/Basigin) and antibodies directed against antigenic determinants within the peptides. Pharmaceutical compositions including the peptides and antibodies and methods of their production and use in vaccination, immunotherapy and diagnosis of proliferative, hyperpermeability, inflammatory, and angiogenesis-related diseases and disorders.... Mor Research Applications

Methods of using pigment epithelium derived factor (pedf) for the treatment and prevention of agent-induced gonadal or uterine toxicity

A method of treating or preventing gonadal or uterine toxicity induced by an agent in a subject is provided. Accordingly there is provided a method comprising administering to a subject a therapeutically effective amount of pigment epithelium-derived factor (PEDF), thereby treating or preventing the gonadal toxicity induced by the agent.... Mor Research Applications

Butyroyloxymethyl diethyl phosphate compounds and uses thereof

Methods for treating ameliorating, reducing and/or preventing a cutaneous T-cell lymphoma in a subject in need thereof, comprising administration butyroyloxymethyl diethyl phosphate (AN-7) alone or combined with an additional anti-cancer therapy.... Mor Research Applications

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009


This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. is not affiliated or associated with Mor Research Applications in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Mor Research Applications with additional patents listed. Browse our Agent directory for other possible listings. Page by